The same analysis reported the common features of the associated lung cancer, including the adenocarcinoma pathology and at least one driver mutation in nearly half of the cases, including KRAS, EGFR, ALK, BRAF, and ATM [6]. This evidence concerns the gene KRAS and lung carcinoma.